Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun Kim, In Hee Kim, on behalf of the Korean Association for the Study of the Liver (KASL)
Received May 9, 2026 Accepted June 2, 2026 Published online June 12, 2026
Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
Clin Mol Hepatol 2023;29(3):779-793. Published online May 15, 2023
Background/Aims To eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) according to the World Health Organization (WHO) criteria in 2021, this study investigated the national core indicators representing the current status of viral hepatitis B and C in South Korea.
Methods We analyzed the incidence, linkage-to-care, treatment, and mortality rates of HBV and HCV infection using the integrated nationwide big data of South Korea.
Results According to data from 2018–2020, the incidence of acute HBV infection in South Korea was 0.71 cases per 100,000 population; tthe linkage-to-care rate was only 39.4%. Among those who need hepatitis B treatment, the treatment rate was 67.3%, which was less than 80% reported in the WHO program index. The annual liver-related mortality due to HBV was 18.85 cases per 100,000 population, exceeding the WHO target of four; the most frequent cause of death was liver cancer (54.1%). The annual incidence of newly diagnosed HCV infection was 11.9 cases per 100,000 population, which was higher than the WHO impact target of five. Among HCV-infected patients, the linkage-to-care rate was 65.5% while the treatment rate was 56.8%, which were below the targets of 90% and 80%, respectively. The liver-related annual mortality rate due to HCV infection was 2.02 cases per 100,000 population.
Conclusions Many of the current indicators identified in the Korean population did not satisfy the WHO criteria for validation of viral hepatitis elimination. Hence, a comprehensive national strategy should be urgently developed with continuous monitoring of the targets in South Korea.
Citations
Citations to this article as recorded by
Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgery Jae Seung Lee, Ho Soo Chun, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Infection and Public Health.2026; 19(2): 103076. CrossRef
2025 KASL clinical practice guidelines for management of hepatitis C Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
Hepatitis B in Africa: Progress toward World Health Organization 2030 targets, persistent disparities, and COVID-19 setbacks Kui Wang, Ruchen Zhou Clinical and Molecular Hepatology.2026; 32(2): e211. CrossRef
In-Hospital Hepatitis C Alarm System: A Strategy to Enhance Linkage to Care for Hepatitis C Virus Infection Jaehong Jeong, Chang Hyeong Lee, Byung Seok Kim, Jeong Eun Song Gut and Liver.2026; 20(3): 474. CrossRef
AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatment Huapeng Lin, Terry Cheuk-Fung Yip, Hye Won Lee, Xiangjun Meng, Jimmy Che-To Lai, Sang Hoon Ahn, Wenjing Pang, Grace Lai-Hung Wong, Lingfeng Zeng, Vincent Wai-Sun Wong, Victor de Lédinghen, Seung Up Kim Journal of Hepatology.2025; 82(3): 456. CrossRef
Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021 Si Yang, Yujiao Deng, Yi Zheng, Jing Zhang, Dongdong He, Zhijun Dai, Changcun Guo Hepatology International.2025; 19(2): 441. CrossRef
Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults Donghee Kim, Won Kim, Aijaz Ahmed Clinical and Molecular Hepatology.2025; 31(1): e5. CrossRef
Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev Сибирский научный медицинский журнал.2025; 45(1): 6. CrossRef
HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of dis Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn Clinical and Molecular Hepatology.2025; 31(2): e163. CrossRef
Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiven Eun Sun Jang Clinical and Molecular Hepatology.2025; 31(2): 596. CrossRef
Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005–2022) Hwa Young Choi, Moran Ki BMC Public Health.2025;[Epub] CrossRef
Correspondence to letter to the editor on “Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults” Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong Clinical and Molecular Hepatology.2025; 31(2): e149. CrossRef
Incidence of Osteopenia or Osteoporosis in Asian Patients With Chronic Hepatitis B Hye Won Lee, Sungshin Kwon, Yeo Rae Moon, Hyunjung Ahn, Juyeon Lee, Sang‐Hoon Ahn Journal of Gastroenterology and Hepatology.2025; 40(6): 1586. CrossRef
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, Maria Buti, Loreta A Kondili, C Wendy Spearman, Nishi Prabdial-Sing, Victoria Turnier, Jeffrey V Lazarus, Imam Waked, John W Ward, Angelica Miranda, Aya Sugiyama, Behzad Hajarizadeh, Carlos Varaldo, Ca The Lancet Gastroenterology & Hepatology.2025; 10(7): 671. CrossRef
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis Alexander J Stockdale, Bethany Holt, Ajeet Singh Bhadoria, Abhishek Sadasivan, Daniel Ikeda, Todd Pollack, Janus P Ong, Thuy Pham, David B Duong, Vy Nguyen, Gibril Ndow, Roger Chou, Philippa Easterbrook The Lancet Gastroenterology & Hepatology.2025; 10(11): 1013. CrossRef
Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study Gwang Hyeon Choi, Young-Hoon Chon, Do Hoon Kwon, Sung Nam Jo, Og-Jin Jang, Kyung-Ah Kim, Dahye Baik, Eun Sun Jang, Sook-Hyang Jeong Gut and Liver.2025; 19(5): 725. CrossRef
Etiological, Epidemiological, and Medical-Economic Aspects of Hepatocellular Carcinoma (A Review) N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev Cell and Tissue Biology.2025; 19(6): 525. CrossRef
Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study Domenico Pascucci, Aina Nicolàs, Abdelrahman Taha, Jeffrey V Lazarus, Matteo Di Pumpo, Vittoria Tricomi, Francesco Di Berardino, Carlo La Vecchia, José A Perez-Molina, Giuseppe Colucci, Camila A Picchio, Angelo Maria Pezzullo, Stefania Boccia Journal of Global Health.2025;[Epub] CrossRef
Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go BMC Infectious Diseases.2025;[Epub] CrossRef
Epidemiology and Management of Hepatitis C in Korea Jaeyoun Cheong Korean Journal of Healthcare-Associated Infection Control and Prevention.2025; 30(2): 118. CrossRef
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort study Won Sohn, Soo Young Park, Tae Hee Lee, Young Eun Chon, In Hee Kim, Byung-Seok Lee, Ki Tae Yoon, Jae Young Jang, Yu Rim Lee, Su Jong Yu, Won-Mook Choi, Sang Gyune Kim, Dae Won Jun, Joonho Jeong, Ji Hoon Kim, Eun Sun Jang, Hwi Young Kim, Sung Bum Cho, Byoun eClinicalMedicine.2024; 73: 102671. CrossRef
Linvencovir: Paving the way for functional cure in hepatitis B Jiwon Yang, Jonggi Choi Clinical and Molecular Hepatology.2024; 30(2): 164. CrossRef
Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitis Makiko Kimura, Tomoki Nishikawa, Tetsuro Shimakami, Takeshi Terashima, Rika Horii, Masako Fukuda, Mika Yoshita, Noboru Takata, Tomoyuki Hayashi, Masaya Funaki, Kouki Nio, Hajime Takatori, Kuniaki Arai, Tatsuya Yamashita, Masao Honda, Junko Tanaka, Shuichi Global Health & Medicine.2024; 6(6): 404. CrossRef
Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease Marta Belka, Aleksandra Gostyńska-Stawna, Maciej Stawny, Violetta Krajka-Kuźniak International Journal of Molecular Sciences.2024; 25(20): 11213. CrossRef
Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study” Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong Clinical and Molecular Hepatology.2024; 30(4): 997. CrossRef
Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study” Eun Ju Cho Clinical and Molecular Hepatology.2024; 30(4): 663. CrossRef
Background/Aims The role of serum myokine levels in sarcopenia and the outcome of hepatocellular carcinoma (HCC) patients are not clear. This study investigated the serum levels of myostatin, follistatin, and interleukin-6 (IL-6) in HCC patients and their association with sarcopenia and survival.
Methods Using prospectively collected pretreatment samples from 238 HCC patients in a hospital from 2012 to 2015, the serum levels of 3 myokines were determined and compared to 50 samples from age and sex-matched healthy controls. Sarcopenia was evaluated using the psoas muscle index (PMI) measured at the third lumbar level in the computed tomography, and clinical data were collected until 2017.
Results The median levels of the 3 myokines for the male and female HCC patients were as follow: myostatin (3,979.3 and 2,976.3 pg/mL), follistatin (2,118.5 and 2,174.6 pg/mL), and IL-6 (2.5 and 2.7 pg/mL), respectively. Those in the HCC patients were all significantly higher than in the healthy controls. In the HCC patient, the median PMI was 4.43 (males) and 2.17 cm2/m2 (females) with a sarcopenic prevalence of 56.4%. The serum levels of myostatin, IL-6 and follistatin in the HCC patients showed a positive, negative, and no correlation with PMI, respectively. The serum follistatin level was an independent factor for poor survival in HCC patients.
Conclusions The serum levels of myostatin, follistatin, and IL-6 and their correlation with sarcopenia and survival were presented in HCC patients for the first time. The role of the serum follistatin level as a poor prognostic biomarker warrants further study.
Citations
Citations to this article as recorded by
A non-invasive decision tree predicting recurrence-free survival after liver transplantation for hepatocellular carcinoma Mo-Dan Yang, Jian-Yong Zhuo, Guo-Ying Wang, Li Zhuang, Xiao Xu, Shu-Sen Zheng, Yang Yang, Di Lu Hepatobiliary & Pancreatic Diseases International.2026; 25(1): 23. CrossRef
Diagnostic Performance of Serum Adiponectin and a Biomarker-Based Model for Sarcopenia in Compensated Cirrhosis Kanachai Boonpiraks, Phatcharapong Thaweesukolrat, Piyaporn Surinlert, Kanta Pranweerapaiboon, Sith Siramolpiwat Journal of Clinical and Experimental Hepatology.2026; 16(3): 103524. CrossRef
Immunonutrition interventions for sarcopenia in cancer patients: A systematic review and meta-analysis of randomized controlled trials Li-Mei Wang, Jia-Yi Zhang, Cheng Liu, Cai-Mei Chen, Chun-Mei Wang, Fang Fang, Dong Tang, Jing-Qiu Zhang Journal of Nutritional Oncology.2026; 11(1): 19. CrossRef
Risk Factors for Tumor-Associated
Sarcopenia: A Meta-Analysis 婷婷 李 Advances in Clinical Medicine.2026; 16(04): 2115. CrossRef
High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients Yihua Dai, Baoying Pan, Jiali Zhao, Shanglin Cai, Jian Li, Baojia Zou Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
The Role of Myokines in Liver Diseases Hiroki Nishikawa, Soo Ki Kim, Akira Asai International Journal of Molecular Sciences.2025; 26(3): 1043. CrossRef
Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi Hepatology Research.2025; 55(5): 631. CrossRef
The emerging role of exercise preconditioning in preventing skeletal muscle atrophy Xu Zhou, Shiming Li, Lu Wang, Jun Wang, Peng Zhang, Xiaoping Chen Frontiers in Physiology.2025;[Epub] CrossRef
New insights into biomarkers and risk stratification to predict hepatocellular cancer Katrina Li, Brandon Mathew, Ethan Saldanha, Puja Ghosh, Adrian R. Krainer, Srinivasan Dasarathy, Hai Huang, Xiyan Xiang, Lopa Mishra Molecular Medicine.2025;[Epub] CrossRef
The association between shorter disease course and sarcopenia in women with endometriosis: a retrospective analysis of NHANES 1999–2006 Litao Sun, Yishu Tian, Lei Ling Scientific Reports.2025;[Epub] CrossRef
State-of-the-art insights into myokines as biomarkers of sarcopenia: a literature review Omar R Moussaoui International Journal of Physiology, Pathophysiology and Pharmacology.2025; 17(3): 80. CrossRef
Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n-3 PUFA Supplementation Alejandro Martínez-Gayo, Elisa Félix-Soriano, Javier Ibáñez-Santos, Marisol García-Unciti, Pedro González-Muniesa, María J. Moreno-Aliaga Nutrients.2025; 17(15): 2553. CrossRef
Exerkines and myokines in aging sarcopenia Huan Wang, Wenbi He, Peishan Chen, Haozhe Wang, Huiguo Wang, Lin Zhu, Xiaoguang Liu Frontiers in Endocrinology.2025;[Epub] CrossRef
Alpha‐Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models Pooreum Lim, Sang Woo Woo, Jihye Han, Young Lim Lee, Jin Ju Lim, Yeong Hoon Kang, Ji Wook Moon, Jeong Min Nam, Jeong Hyeon Kim, Donghun Kim, Jae Ho Shim, Hyeon Soo Kim Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Associations Among Skeletal Muscle Mass, Bone Mineral Density, and Cardiometabolic Risk Factors in Young and Middle-Aged Adults Yeonhwi Kim, Minje Ji, Sewon Lee Exercise Science.2025; 34(3): 308. CrossRef
Alterations in the Myokine Concentrations in Relation to Sarcopenia and Sleep Disturbances: A Narrative Review Michalina Knapik, Jakub Kuna, Grzegorz Chmielewski, Łukasz Jaśkiewicz, Magdalena Krajewska-Włodarczyk Journal of Clinical Medicine.2025; 14(18): 6527. CrossRef
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers Justyna Rentflejsz, Zyta Beata Wojszel Journal of Clinical Medicine.2024; 13(4): 1107. CrossRef
Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak, Ewa Małecka-Wojciesko Nutrients.2024; 16(6): 810. CrossRef
Hepatocellular carcinoma and musculoskeletal system: A narrative literature review Jelena Jadzic, Danijela Djonic World Journal of Gastroenterology.2024; 30(15): 2109. CrossRef
Role of Myostatin in Rheumatoid Arthritis: A Review of the Clinical Impact Fabiola Gonzalez-Ponce, Melissa Ramirez-Villafaña, Eli Efrain Gomez-Ramirez, Ana Miriam Saldaña-Cruz, Sergio Gabriel Gallardo-Moya, Norma Alejandra Rodriguez-Jimenez, Heriberto Jacobo-Cuevas, Cesar Arturo Nava-Valdivia, Felipe Alexis Avalos-Salgado, Sylvi Diagnostics.2024; 14(11): 1085. CrossRef
Exploring the impact of interleukins on sarcopenia development: A systematic review and meta-analysis Yan He, Wenrong Duan, Ping Xu, Taiping Lin, Qiao Xiang, Birong Dong, Ning Ge, Jirong Yue Experimental Gerontology.2024; 193: 112480. CrossRef
Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity Laura Orioli, Sofia Samaras, Kiswendsida Sawadogo, Marie de Barsy, Pascale Lause, Yannick Deswysen, Benoit Navez, Jean-Paul Thissen, Audrey Loumaye Clinical Nutrition.2024; 43(7): 1800. CrossRef
Follistatin-respiratory connection predicting all-cause mortality among community-dwelling middle-to-old age individuals: Results from the I-Lan Longitudinal Study Hsiao-Chin Shen, Wei-Ju Lee, Chuan-Yen Sun, Wen-Kuang Yu, Wei-Chih Chen, Fei-Yuan Hsiao, Kuang-Yao Yang, Liang-Kung Chen The Journal of nutrition, health and aging.2024; 28(8): 100285. CrossRef
Epigenetics of Skeletal Muscle Atrophy Jiacheng Du, Qian Wu, Eun Ju Bae International Journal of Molecular Sciences.2024; 25(15): 8362. CrossRef
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis Chiyu He, Zhihang Hu, Zuyuan Lin, Hao Chen, Chenghao Cao, Jinyan Chen, Xudong Yang, Huigang Li, Wei Shen, Xuyong Wei, Li Zhuang, Shusen Zheng, Xiao Xu, Di Lu BMC Cancer.2024;[Epub] CrossRef
Association of interleukin-6 with sarcopenia and its components in older adults: a systematic review and meta-analysis of cross-sectional studies Jie Ding, Guangyue Yang, Wen Sun, Yifei Li, Ning Wang, Jiening Wang, Yongfang Zhao Annals of Medicine.2024;[Epub] CrossRef
NADPH oxidase 4 deficiency promotes hepatocellular carcinoma arising from hepatic fibrosis by inducing M2-macrophages in the tumor microenvironment Ji Young Kim, Wonseok Kang, Sera Yang, Su Hyun Park, Sang Yun Ha, Yong-Han Paik Scientific Reports.2024;[Epub] CrossRef
Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis Di-Hang Wu, Cheng-Yu Liao, Dan-Feng Wang, Long Huang, Ge Li, Jiang-Zhi Chen, Liang Wang, Tian-Sheng Lin, Jian-Lin Lai, Song-Qiang Zhou, Fu-Nan Qiu, Zhi-Bo Zhang, Yan-Ling Chen, Yao-Dong Wang, Xiao-Chun Zheng, Yi-Feng Tian, Shi Chen European Journal of Surgical Oncology.2023; 49(4): 802. CrossRef
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Do Seon Song, U Im Chang, Jin Mo Yang Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zheng Scientific Reports.2023;[Epub] CrossRef
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts Yunjian Wu, Kimberley C. Clark, Birunthi Niranjan, Anderly C. Chüeh, Lisa G. Horvath, Renea A. Taylor, Roger J. Daly Molecular Oncology.2023; 17(3): 469. CrossRef
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, Johanne Poisson, Maxime Frelaut, Coline Montégut, Soraya Mebarki, Romain Geiss, Zoé ap Thomas, Aurélien Noret, Monica Pierro, Capucine Baldini, Elena Paillaud, Frédéric Pamoukdjian Nutrients.2023; 15(5): 1193. CrossRef
Interaction between sarcopenia and nonalcoholic fatty liver disease Sae Kyung Joo, Won Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef
Review article: Putting some muscle into sarcopenia—the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease Stephanie L. Gold, Maitreyi Raman, Bruce E. Sands, Ryan Ungaro, João Sabino Alimentary Pharmacology & Therapeutics.2023; 57(11): 1216. CrossRef
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients Andrea Dalbeni, Leonardo Antonio Natola, Marta Garbin, Mirko Zoncapè, Filippo Cattazzo, Anna Mantovani, Antonio Vella, Stefania Canè, Jasmin Kassem, Michele Bevilacqua, Simone Conci, Tommaso Campagnaro, Andrea Ruzzenente, Alessandra Auriemma, Alessandro D Cancers.2023; 15(9): 2406. CrossRef
Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis Jiye Liu, Hanyong Luo, Letian Huang, Jiahe Wang Oncology Letters.2023;[Epub] CrossRef
Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review Amirhossein Ahmadi Hekmatikar, André Nelson, Aaron Petersen BMC Cancer.2023;[Epub] CrossRef
Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis Shanshan Guo, Yonghao Feng, Xiaopeng Zhu, Xinyi Zhang, Hui Wang, Ruwen Wang, Qiongyue Zhang, Yiming Li, Yan Ren, Xin Gao, Hua Bian, Tiemin Liu, Huanqing Gao, Xingxing Kong Nature Communications.2023;[Epub] CrossRef
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis Xuanmei Li, Xue Huang, Lifu Lei, Shiwen Tong Frontiers in Nutrition.2023;[Epub] CrossRef
Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture Renwang Sheng, Mumin Cao, Mingyuan Song, Mingyue Wang, Yuanwei Zhang, Liu Shi, Tian Xie, Yingjuan Li, Jinyu Wang, Yunfeng Rui Journal of Orthopaedic Translation.2023; 43: 36. CrossRef
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Saurabh Chandan, Benjamin Tharian, Ragesh Babu Thandassery World Journal of Gastroenterology.2022; 28(4): 432. CrossRef
Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells Abhilasha Srivastava, Harshita Sharma, Simran Khanna, Tejasvini Sadhu Balasundaram, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee Frontiers in Oncology.2022;[Epub] CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Scientific Reports.2022;[Epub] CrossRef
A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction Myung-Rae Cho, Sungho Lee, Suk-Kyoon Song Journal of Korean Medical Science.2022;[Epub] CrossRef
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman Journal of Cellular Biochemistry.2022; 123(10): 1553. CrossRef
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma Hiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Hayakawa, Yutaka Yasui, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Taisei Keitoku, Tsubasa Nobusawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chia Cancers.2022; 14(14): 3551. CrossRef
CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study Siwei Yang, Zhiyuan Zhang, Tianhao Su, Jianan Yu, Shasha Cao, Haochen Wang, Long Jin European Journal of Medical Research.2022;[Epub] CrossRef
Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study Angeliki Kotti, Annica Holmqvist, Mischa Woisetschläger, Xiao-Feng Sun Cancer & Metabolism.2022;[Epub] CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
What Is the Role of Body Composition Assessment in HCC Management? Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour Cancers.2022; 14(21): 5290. CrossRef
The effect of sarcopenia and serum myokines on prognosis and survival in cirrhotic patients: a multicenter cross-sectional study Salih Boga, Abdullah Emre Yildirim, Enver Ucbilek, Ali Riza Koksal, Sevil Tokdemir Sisman, Ibrahim Durak, Ilker Sen, Beril Dogu, Erdinc Serin, Ayse Bolat Ucbilek, Makbule Ozge Yildirim, Sukru Mehmet Erturk, Huseyin Alkim, Canan Alkim European Journal of Gastroenterology & Hepatology.2022; 34(12): 1261. CrossRef
Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis Chuan Jiang, Yanyan Wang, Wei Fu, Guozhuan Zhang, Xiaoshan Feng, Xing Wang, Fang Wang, Le Zhang, Yang Deng Frontiers in Nutrition.2022;[Epub] CrossRef
Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans Grigorios Panagiotou, Wael Ghaly, Jagriti Upadhyay, Kalliopi Pazaitou-Panayiotou, Christos S Mantzoros The Journal of Clinical Endocrinology & Metabolism.2021; 106(5): e2137. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Qiang Li, Lei Zhang, Zhong-Heng Hou, Dong-Xu Zhao, Jian-Bin Li, Shuai Zhang, Yu Yin, Cai-Fang Ni, Tao Chen Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women Yanping Du, Cuidi Xu, Hongli Shi, Xin Jiang, Wenjing Tang, Xiaoqing Wu, Minmin Chen, Huilin Li, Xuemei Zhang, Qun Cheng BMC Geriatrics.2021;[Epub] CrossRef
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review Rashmi Supriya, Kumar Purnendu Singh, Yang Gao, Feifei Li, Frédéric Dutheil, Julien S. Baker Biology.2021; 10(12): 1354. CrossRef
Irisin in Liver Cirrhosis Michał Kukla, Lubomir Skladany, Tomasz Menżyk, Aleksandra Derra, Dominika Stygar, Magdalena Skonieczna, Dorota Hudy, Katarzyna Nabrdalik, Janusz Gumprecht, Wojciech Marlicz, Anastasios Koulaouzidis, Tomas Koller Journal of Clinical Medicine.2020; 9(10): 3158. CrossRef
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma Sooyeon Oh, Jooho Lee Clinical and Molecular Hepatology.2020; 26(4): 476. CrossRef
First
Prev
